Search for EvidenceBased Medicine for Brugada Syndrome
The paper by Nademanee et al. (1) is so excellent-it demonstrated that the proposed diagnosis of idiopathic origin for the so-called Brugada syndrome must be dismissed.
There are 2 minor criticisms: one is that not one of the patients submitted to necropsy had an electrocardiogram (ECG) performed during life, so it is possibly but not definitely sure that they have the complete phenotypic traits. It is also confusing why, because this lethal syndrome has been proposed to be the "mother" of a relevant number of sudden deaths, it has been so difficult to perform detailed necropsy studies in patients who have died because of the syndrome, and why those published have been so rarely discussed (see Table 1 of Martini et al. [2] ).
As a second comment, I find it unfair in this paper that the humble but first discoverer of the syndrome (and its underlying structural abnormalities), Professor Andrea Nava from Padova, was not even cited. Please note: Dr. Martini has reported that he has no relationships relevant to the contents of this paper to disclose. Limitations on reference numbers meant that we were unable to refer to all manuscripts worthy of inclusion. We included only sudden arrhythmic death syndrome cases in our cohort, that is, ostensibly structurally normal hearts. The subsequent finding of subtle fibrosis in the right ventricular outflow tract in these cases represents 1 end of the spectrum of the Brugada syndrome phenotype, the other end being described by Nava. 
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